Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clicks GroupCLCGY +1.96%83 EV-to-EBITDA is 8.03 as of Jul. 31, 2026, which is 50% below its 10-year median of 16.04. GuruFocus rates CLCGY with a GF Score™ of 83/100 and a GF Value™ of $50.04 (Significantly Undervalued). Among 509 Healthcare Providers & Services companies, Clicks Group ranks better than 68.76% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Clicks Group's enterprise value is $3,304 Mil.
Clicks Group's EBITDA for the trailing twelve months (TTM) ended in Feb. 2026 was $411 Mil. Therefore, Clicks Group's EV-to-EBITDA for today is 8.03.
The historical rank and industry rank for Clicks Group's EV-to-EBITDA or its related term are showing as below:
CLCGY'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.56 Med: 16.04 Max: 25.12
Current: 8.03
During the past 13 years, the highest EV-to-EBITDA of Clicks Group was 25.12. The lowest was 7.56. And the median was 16.04.
CLCGY's EV-to-EBITDA is ranked better than 68.76% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.04
vs CLCGY: 8.03
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Clicks Group (OTCPK:CLCGY) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Clicks Group's PE Ratio (TTM) for today is calculated as:
Clicks Group's share price for today is $26.885.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Clicks Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was $1.676.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Clicks Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Clicks Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clicks Group EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clicks Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Clicks Group's EV-to-EBITDA falls into.
Clicks Group's current Enterprise Value is $3,304 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Clicks Group's EBITDA for the trailing twelve months (TTM) ended in Feb. 2026 was $411 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clicks Group (CLCGY) has a EV-to-EBITDA of 8.03 as of Jul. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Clicks Group. This is 50% below median its historical median of 16.04. Over the past decade, Clicks Group's EV-to-EBITDA has ranged from 7.56 to 25.12. According to the industry distribution chart, Clicks Group ranks #159 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 31.2%.
Is Clicks Group's EV-to-EBITDA too high?
Clicks Group's current EV-to-EBITDA of 8.03 is 50% below median its 10-year median of 16.04. Over the past 10 years, this metric has ranged from a low of 7.56 to a high of 25.12. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.04. Clicks Group's value of 8.03 is 27.3% below this industry median. Based on the distribution chart, Clicks Group ranks #159 out of 509 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Clicks Group has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clicks Group's EV-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Clicks Group ranks #159 out of 509 companies for EV-to-EBITDA. This puts Clicks Group in the upper half of its industry. The industry median EV-to-EBITDA is 11.04. Clicks Group's value of 8.03 is 27.3% below this benchmark. Historically, Clicks Group's own EV-to-EBITDA has ranged from 7.56 to 25.12 over the past decade. While the company's 10-year median is 16.04 vs. the industry median of 11.04, Clicks Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.04, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clicks Group's current EV-to-EBITDA of 8.03 is 27.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Clicks Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clicks Group's current EV-to-EBITDA is 8.03, which is 50% below median its own 10-year median of 16.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clicks Group stock overvalued right now?
Based on GuruFocus' analysis, Clicks Group (CLCGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $50.04, compared to a current price of $26.89 — trading 46.3% below its estimated fair value. The current EV-to-EBITDA is 8.03, which is 50% below median its 10-year median of 16.04 and 27.3% below the Healthcare Providers & Services industry median of 11.04. Clicks Group's overall GF Score™ is 83/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Clicks Group (CLCGY), the current EV-to-EBITDA is 8.03 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clicks Group (CLCGY) Overvalued in 2026?
Based on GuruFocus' analysis, Clicks Group stock appears to be undervalued.
The current stock price of $26.89 is trading 46.3% below its estimated GF Value™ of $50.04.
GuruFocus considers Clicks Group to be Significantly Undervalued.
Key valuation signals for CLCGY:
EV-to-EBITDA: 8.03 (50% below median its 10-year median of 16.04)
GF Value™: $50.04 vs. price of $26.89 (46.3% below fair value)
Industry Position: 27.3% below the Healthcare Providers & Services median (#159 of 509)
No single metric tells the full story. See the CLCGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clicks Group Ltd operates prominently in health, beauty, and wellness retail across southern Africa. The company predominantly operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company has a portfolio of retail franchise brands including The Body Shop, M-Kem, and Sorbet among others. The company's business segments include Retail and Distribution. The company generates revenue from in-store and online sales of health, beauty, and wellness items, plus wholesale pharmaceutical distribution. Geographically, the maximum revenue is generated from South Africa.
83GF Score
Get the complete analysis for CLCGY
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLCGY has been successfully added to your 
